pillbase.ru

Гарвони®

Active substance: Ледипасвир, Софосбувир

таблетки, покрытые пленочной оболочкой, 90 мг+400 мг (original in Russian, GRLS)

RussiaActive

Marketing holder: Гилеад Сайенсиз Интернешнл Лимитед

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Products containing ledipasvir in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 5
  • Harvoni
    TABLET, FILM COATED · LEDIPASVIR 90 mg/1, SOFOSBUVIR 400 mg/1
    61958-1801
    Gilead Sciences, Inc
  • Harvoni
    PELLET · LEDIPASVIR 33.75 mg/1, SOFOSBUVIR 150 mg/1
    61958-1805
    Gilead Sciences, Inc
  • Harvoni
    PELLET · LEDIPASVIR 45 mg/1, SOFOSBUVIR 200 mg/1
    61958-1804
    Gilead Sciences, Inc
  • Harvoni
    TABLET, FILM COATED · LEDIPASVIR 45 mg/1, SOFOSBUVIR 200 mg/1
    61958-1803
    Gilead Sciences, Inc
  • Ledipasvir and Sofosbuvir
    TABLET, FILM COATED · LEDIPASVIR 90 mg/1, SOFOSBUVIR 400 mg/1
    72626-2601
    Asegua Therapeutics LLC
EU 1
  • Harvoni
    ledipasvir, sofosbuvir
    EMEA/H/C/003850
    Gilead Sciences Ireland UC
Registration
Registration number
ЛП-006104
Registration status
Active
Dispensing
Prescription only
Release forms
таблетки, покрытые пленочной оболочкой, 90 мг+400 мг, 28 шт. - флаконы - короба (28 шт.) - In-Bulk; show all (2)таблетки, покрытые пленочной оболочкой, 90 мг+400 мг, 28 шт. - флаконы - короба (28 шт.) - In-Bulk; таблетки, покрытые пленочной оболочкой, 90 мг+400 мг, 28 шт. - флаконы - пачки картонные (28 шт.) - По рецепту;
(original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-006104 · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-006104 · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-006104 · Verified 2026-10-09
  • ingredients.1 · GRLS (Russian state register) · ЛП-006104 · Verified 2026-10-09